Literature DB >> 8548122

Multiple occurrence of borderline hepatocellular nodules in human cirrhotic livers: possible multicentric origin of hepatocellular carcinoma.

T Terada1, Y Nakanuma.   

Abstract

Borderline hepatocellular nodules (BHN), atypical adenomatous hyperplasia, macroregenerative nodule type II or dysplastic nodules in the cirrhotic liver are considered to be important prcancerous lesions transforming to hepatocellular carcinoma (HCC). In order to evaluate the uni- or multicentric origin of BHN and HCC arising from BN, we surveyed 30 cirrhotic livers with BHNs that had been surgically resected or autopsied during 1973-1993. Among the 30 cirrhotic livers with BHNs, two or more BHNs were present in a single cirrhotic liver in 10 (33%) cases, while only one BHN was present in a single cirrhotic liver in the remaining 20 (67%) cases. The mean number of BHN in a cirrhotic liver with multiple BHNs was 3.5. Carcinomatous foci were present within BHN in 6 (60%) of the 10 cirrhotic livers with multiple BHNs, while they were present in 4 (20%) of the 20 cirrhotic livers with a single BHN; this difference was statistically significant (P < 0.05). Coexistance of HCC was noted in 8 (80%) of the 10 cirrhotic livers with multiple BHNs, and in 3 (15%) of the 20 cirrhotic livers with a single BHN; this difference was statistically significant (P < 0.01). There were no significant differences in age, sex, aetiology and morphology between cirrhotic livers with multiple BHNs and those with a single BHN. These data suggest that BHN and HCC arising from BHN may be of multicentric origin.

Entities:  

Mesh:

Year:  1995        PMID: 8548122     DOI: 10.1007/bf00199386

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  20 in total

Review 1.  Preneoplastic lesions as end points in carcinogenicity testing. I. Hepatic preneoplasia.

Authors:  P Bannasch
Journal:  Carcinogenesis       Date:  1986-05       Impact factor: 4.944

2.  Proposal for standardized criteria for the diagnosis of benign, borderline, and malignant hepatocellular lesions arising in chronic advanced liver disease.

Authors:  L D Ferrell; J M Crawford; A P Dhillon; P J Scheuer; Y Nakanuma
Journal:  Am J Surg Pathol       Date:  1993-11       Impact factor: 6.394

3.  Clonal origin of recurrent hepatocellular carcinomas.

Authors:  P J Chen; D S Chen; M Y Lai; M H Chang; G T Huang; P M Yang; J C Sheu; S C Lee; H C Hsu; J L Sung
Journal:  Gastroenterology       Date:  1989-02       Impact factor: 22.682

4.  Clonal origin of atypical adenomatous hyperplasia of the liver and clonal identity with hepatocellular carcinoma.

Authors:  H Tsuda; S Hirohashi; Y Shimosato; M Terada; H Hasegawa
Journal:  Gastroenterology       Date:  1988-12       Impact factor: 22.682

5.  Cell proliferative activity in adenomatous hyperplasia of the liver and small hepatocellular carcinoma. An immunohistochemical study demonstrating proliferating cell nuclear antigen.

Authors:  T Terada; Y Nakanuma
Journal:  Cancer       Date:  1992-08-01       Impact factor: 6.860

6.  Histopathological and morphometric analysis of atypical adenomatous hyperplasia of human cirrhotic livers.

Authors:  T Terada; K Ueda; Y Nakanuma
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

7.  Multiple hepatocellular carcinomas at the early stage have different clonality.

Authors:  J C Sheu; G T Huang; H C Chou; P H Lee; J T Wang; H S Lee; D S Chen
Journal:  Gastroenterology       Date:  1993-11       Impact factor: 22.682

8.  Lack of intratumoral heterogeneity in DNA ploidy pattern of hepatocellular carcinoma.

Authors:  N Nagasue; H Kohno; T Hayashi; A Yamanoi; M Uchida; Y Takemoto; Y Makino; T Ono; J Hayashi; T Nakamura
Journal:  Gastroenterology       Date:  1993-11       Impact factor: 22.682

9.  Liver cell dysplasia: a premalignant condition.

Authors:  P P Anthony; C L Vogel; L F Barker
Journal:  J Clin Pathol       Date:  1973-03       Impact factor: 3.411

10.  Mutation pattern of the p53 gene as a diagnostic marker for multiple hepatocellular carcinoma.

Authors:  T Oda; H Tsuda; A Scarpa; M Sakamoto; S Hirohashi
Journal:  Cancer Res       Date:  1992-07-01       Impact factor: 12.701

View more
  3 in total

1.  A case of small well-differentiated hepatocellular carcinoma with marked lymphocytic infiltrate.

Authors:  Tomohiro Iwasaki; Aki Kubota; Makoto Suzuki; Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2020-03-01

2.  Combined hepatocellular-cholangiocarcinoma with stem cell features, ductal plate malformation subtype: a case report and proposal of a new subtype.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2013-03-15

3.  Comparative histomorphological review of rat and human hepatocellular proliferative lesions.

Authors:  Bob Thoolen; Fiebo J W Ten Kate; Paul J van Diest; David E Malarkey; Susan A Elmore; Robert R Maronpot
Journal:  J Toxicol Pathol       Date:  2012-10-01       Impact factor: 1.628

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.